Categories newsmakers | 1980sPosted on

Amy W. Schulman ’82

Amy W. Schulman ’82 was named senior vice president and general counsel of Pfizer Inc., effective June 23. She joined Pfizer from the global law firm DLA Piper, where she served on the Global Board and U.S. Executive and Policy committees. She also spearheaded a number of the firm’s strategic initiatives, most notably in the areas of diversity and inclusiveness. She was co-leader of the firm’s mass tort/class action practice, handling some of the most complicated legal, scientific and regulatory issues facing the world’s most respected companies, including Pfizer, General Electric, and the Altria Group. In a Wall Street Journal article last May, Pfizer’s CEO Jeffrey Kindler said, “Her knowledge of the legal, business and regulatory challenges facing the pharmaceutical industry and her experience tackling large, complex cases make her uniquely qualified to lead Pfizer’s legal team.” She earned her J.D. from Yale University Law School in 1989. AMY W. SCHULMAN '82 was selected from among 600 candidates as one of The American Lawyer magazine's "45 Under 45." A partner with Piper Rudnick's New York office, Schulman, who received her law degree from Yale University, is the only woman on her firm's nine-person Executive Committee. She is also the mother of three children (and has had children, now 13, 9 and 3, at every stage of her career-- "in law school, as an associate and, finally, as a partner"). She specializes in large-scale corporate litigation, working with a team she has built of "extraordinary lawyers." She adds: "I own my clients' problems and when people ask me how (as they invariably do) I juggle all the competing demands, I always return to the fact that I love what I'm doing. Nothing is more exciting to me than helping clients craft solutions. I get to spring into action when a client comes in and says, 'I have a really big, messy problem.'" Her clients include Altria Group Inc., General Electric Company, Wyeth, Johnson & Johnson, and Cisco Systems, Inc.
Amy W. Schulman ’82 was named senior vice president and general counsel of Pfizer Inc., effective June 23. She joined Pfizer from the global law firm DLA Piper, where she served on the Global Board and U.S. Executive and Policy committees. She also spearheaded a number of the firm’s strategic initiatives, most notably in the areas of diversity and inclusiveness. She was co-leader of the firm’s mass tort/class action practice, handling some of the most complicated legal, scientific and regulatory issues facing the world’s most respected companies, including Pfizer, General Electric, and the Altria Group. In a Wall Street Journal article last May, Pfizer’s CEO Jeffrey Kindler said, “Her knowledge of the legal, business and regulatory challenges facing the pharmaceutical industry and her experience tackling large, complex cases make her uniquely qualified to lead Pfizer’s legal team.” She earned her J.D. from Yale University Law School in 1989.
AMY W. SCHULMAN ’82 was selected from among 600 candidates as one of The American Lawyer magazine’s “45 Under 45.” A partner with Piper Rudnick’s New York office, Schulman, who received her law degree from Yale University, is the only woman on her firm’s nine-person Executive Committee. She is also the mother of three children (and has had children, now 13, 9 and 3, at every stage of her career– “in law school, as an associate and, finally, as a partner”). She specializes in large-scale corporate litigation, working with a team she has built of “extraordinary lawyers.” She adds: “I own my clients’ problems and when people ask me how (as they invariably do) I juggle all the competing demands, I always return to the fact that I love what I’m doing. Nothing is more exciting to me than helping clients craft solutions. I get to spring into action when a client comes in and says, ‘I have a really big, messy problem.'” Her clients include Altria Group Inc., General Electric Company, Wyeth, Johnson & Johnson, and Cisco Systems, Inc.